InvestorsHub Logo
Followers 1
Posts 269
Boards Moderated 0
Alias Born 05/08/2017

Re: None

Wednesday, 07/26/2017 3:13:42 PM

Wednesday, July 26, 2017 3:13:42 PM

Post# of 2538
smile Went out of predictions business long time back. I just read the documents and made the best decision with a positive mathematical expectancy.

With FDA there is simply no guarantee.

After reading the FDA Briefing Document and, importantly, the consultant opinion, I believe the probability of approval is in the Long side. I was expecting a $12-$14 price prior to AdComm (unfortunately this does not seem to be panning out). A positive outcome (vote) would value the stock 20-30 % higher. Taking the lower value and a 25% up-marking after AdComm (if positive results) we should have a $15 SP.

FDA approval should take the price to $18-20 (I am not factoring in the value of SD-101, which seems to be forgotten at the moment).

In any case, I am taking positions with these numbers in mind. Hope it happens.

Note: I have been holding a sizable position in DVAX for 8 months now.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent DVAX News